tiprankstipranks
Silence Therapeutics (SLN)
NASDAQ:SLN
US Market

Silence Therapeutics (SLN) Cash flow

352 Followers

Silence Therapeutics Cash Flow

SLN's free cash flow for Q4 2025 was £-17.34M. For the 2025 fiscal year, SLN's free cash flow was decreased by £5.53M and operating cash flow was £-17.29M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
£ -62.27M£ -67.64M£ -39.35M£ -57.04M£ 9.19M
Investing Cash Flow
£ -35.70M£ -21.97M£ 16.43M£ -20.50M£ 11.71M
Financing Cash Flow
£ 11.16K£ 142.09M£ 25.16M£ 52.58M£ 41.45M
End Cash Position
£ 8.37M£ 121.33M£ 54.03M£ 66.27M£ 99.25M
Free Cash Flow
£ -62.33M£ -67.85M£ -39.40M£ -57.59M£ 7.39M
Currency in GBP

Silence Therapeutics Cash Flow